JBIO
Jade Biosciences, Inc. has filed 479 documents with the SEC between 2020 and 2026. The most frequent type is insider trade (178 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| EFFECT | - | 2026-05-15 | - |
| EFFECT | - | 2026-05-15 | - |
| SCHEDULE 13G/A | - | 2026-05-15 | - |
| 424B3 | - | 2026-05-15 | - |
| Employee stock plan | S-8 | 2026-05-07 | - |
| Securities registration | S-3 | 2026-05-07 | - |
| Securities registration | S-3 | 2026-05-07 | - |
| 424B3 | - | 2026-05-07 | - |
| 424B3 | - | 2026-05-07 | - |
| Quarterly report | 10-Q | 2026-05-07 | 2026-03-31 |
| Major company event | 8-K | 2026-05-07 | 2026-05-07 |
| Annual report to shareholders | ARS | 2026-04-28 | 2025-12-31 |
| Proxy materials | DEFA14A | 2026-04-28 | - |
| Proxy statement | DEF 14A | 2026-04-28 | 2026-06-09 |
| SCHEDULE 13G/A | - | 2026-04-27 | - |
| Major company event | 8-K | 2026-04-22 | 2026-04-18 |
| PRE 14A | - | 2026-04-17 | 2026-06-09 |
| Major company event | 8-K | 2026-04-02 | 2026-03-31 |
| Employee stock plan | S-8 | 2026-03-06 | - |
| POS EX | - | 2026-03-06 | - |
| POS EX | - | 2026-03-06 | - |
| 424B3 | - | 2026-03-06 | - |
| 424B3 | - | 2026-03-06 | - |
| Annual report | 10-K | 2026-03-06 | 2025-12-31 |
| Major company event | 8-K | 2026-03-06 | 2026-03-06 |
| SCHEDULE 13D/A | - | 2026-03-05 | - |
| SCHEDULE 13G/A | - | 2026-02-17 | - |
| SCHEDULE 13G | - | 2026-02-17 | - |
| SCHEDULE 13G | - | 2026-02-17 | - |
| Insider trade | 4 | 2026-02-13 | 2026-02-12 |
| Insider trade | 4 | 2026-02-13 | 2026-02-12 |
| Insider trade | 4 | 2026-02-13 | 2026-02-12 |
| Insider trade | 4 | 2026-02-13 | 2026-02-12 |
| SCHEDULE 13G/A | - | 2026-02-13 | - |
| SCHEDULE 13G/A | - | 2026-01-30 | - |
| Major company event | 8-K | 2026-01-05 | 2026-01-05 |
| EFFECT | - | 2025-12-30 | - |
| 424B3 | - | 2025-12-30 | - |
| Company correspondence | CORRESP | 2025-12-23 | - |
| SEC correspondence | UPLOAD | 2025-12-23 | - |
| IPO registration | S-1 | 2025-12-22 | - |
| EFFECT | - | 2025-12-19 | - |
| 424B3 | - | 2025-12-19 | - |
| Major company event | 8-K | 2025-12-15 | 2025-12-13 |
| SCHEDULE 13G/A | - | 2025-11-14 | - |
| IPO registration | S-1 | 2025-11-14 | - |
| Quarterly report | 10-Q | 2025-11-14 | 2025-09-30 |
| Major company event | 8-K | 2025-11-14 | 2025-11-13 |
| SCHEDULE 13G/A | - | 2025-11-14 | - |
| SCHEDULE 13G/A | - | 2025-10-17 | - |